Top Markets
Coin of the day
Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.

TARO
Rank in Stocks #7357
Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven... Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven pharmaceutical enterprise, specializing in the development, manufacturing, and commercialization of both prescription and over-the-counter medications. Its market reach spans the United States, Canada, Israel, and various other international territories. The company also produces active pharmaceutical ingredients (APIs), primarily for integration into its own finished dosage form products. Its extensive product catalog addresses a broad spectrum of medical conditions and therapeutic areas, encompassing treatments for allergies, pain (analgesic), bacterial and fungal infections (antibacterial, antibiotic, antifungal), seizures (anticonvulsant), nausea (antiemetic), inflammation (anti-inflammatory), cancer (anti-cancer, topical anti-neoplastic), blood clot prevention (antiplatelet agent), fever reduction (antipyretic), cardiovascular issues, central nervous system disorders, hormonal regulation (corticosteroid, endocrine), cosmetic applications, coughs and colds, dermatological complaints, fluid management (diuretic), gastrointestinal problems, constipation (laxative), severe pain (narcotics), neuropathic pain, neuropsychiatric conditions, and sleep/anxiety management (sedative/hypnotic). These pharmaceutical goods are available in numerous formats, including capsules, creams, drops, emulsions, gels (and gel kits), granules, injectables, lotions, oils, ointments, pastes, powders (and powders for solution), rectal suppositories, shampoos, solutions (and solutions for infusion), sprays, suspensions, syrups, tablets, toothpastes and mouthwashes, topical foams, and topical solutions. Taro distributes and sells its products directly to a wide array of clients, such as pharmaceutical wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, other direct purchasers, and various healthcare institutions and private pharmacies. The company was established in 1950, with its main offices situated in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a wholly-owned subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.
Share Price
$42.98
Last synced: 2024-06-21
Market Cap
$1.62B
Change (1 day)
0.01%
Change (1 year)
0.00%
Country
IL
Trade Taro Pharmaceutical Industries Ltd. (TARO)

Category

Number of shares outstanding for Taro Pharmaceutical Industries Ltd. (TARO)
Number of shares outstanding as of March 2024: 37.58M
According to Taro Pharmaceutical Industries Ltd. latest financial reports and stock price the company's current number of shares outstanding is 37.58M. At the end of March 2023 the company had 37.58M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Taro Pharmaceutical Industries Ltd. (TARO) from 1999 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 37.58M 0.00%
2024 37.58M 0.00%
2023 37.58M -0.15%
2022 37.64M -1.49%
2021 38.21M -0.65%
2020 38.46M -1.36%
2019 38.99M -2.90%
2018 40.16M -2.77%
2017 41.30M -3.58%
2016 42.83M 0.00%
2015 42.83M -3.26%
2014 44.28M -0.90%
2013 44.68M 0.00%
2012 44.68M 10.94%
2010 40.27M 2.65%
2009 39.23M 0.08%
2008 39.20M 12.89%
2007 34.73M 18.33%
2006 29.35M 0.33%
2005 29.25M 0.36%
2004 29.14M 1.03%
2003 28.85M 0.35%
2002 28.75M 22.75%
2001 23.42M 9.33%
2000 21.42M 6.30%
1999 20.15M 0.00%
Shares Outstanding for similar companies or competitors